WP
ETON icon

Woodline Partners’s Eton Pharmaceutcials ETON Stock Holding History

Woodline Partners’s Portfolio ETON Stock Details ETON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.21M Buy
170,699
+75,212
+79% +$1.32M 0.02% 689
2025
Q4 		$1.61M Buy
+95,487
New +$1.68M 0.01% 797

Other funds holding ETON

OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
NPT
National Philanthropic Trust Jenkintown, Pennsylvania $9.38B AUM 33.37% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
WIM
Westside Investment Management Santa Monica, California $761M AUM 39.85% 1-Year Est. Return

Woodline Partners's ETON Position: Q1 2026 in Review

Woodline Partners increased its Eton Pharmaceutcials (ETON) stake by 79% in Q1 2026, buying an estimated $1.32M and bringing the position to 170,699 shares worth $4.21M. The position accounts for 0.02% of the portfolio, ranked #689.

Woodline Partners first reported a position in ETON in Q4 2025 and has held it in 2 quarters since. 116 funds tracked by Wall St. Rank hold ETON as of Q1 2026.

  • Woodline Partners held 170,699 shares of Eton Pharmaceutcials worth $4.21M as of Q1 2026.
  • Woodline Partners bought 75,212 Eton Pharmaceutcials shares in Q1 2026, an estimated $1.32M.
  • Eton Pharmaceutcials made up 0.02% of Woodline Partners's portfolio in Q1 2026, its #689 holding.
  • Woodline Partners first reported a position in Eton Pharmaceutcials in Q4 2025 and has held it in 2 quarters since.
  • 116 funds tracked by Wall St. Rank held Eton Pharmaceutcials as of Q1 2026.

Based on Woodline Partners's 13F filing for Q1 2026, filed 15 May 2026.